- Report
- October 2024
- 199 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- September 2024
- 100 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- April 2025
- 250 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- November 2024
- 183 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- August 2024
- 150 Pages
Global
From €2538EUR$2,789USD£2,176GBP
- Report
- December 2022
- 153 Pages
Global
From €2389EUR$2,625USD£2,048GBP
€4778EUR$5,250USD£4,096GBP
- Report
- August 2022
- 116 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- April 2023
- 394 Pages
Global
From €6826EUR$7,500USD£5,852GBP
- Clinical Trials
- April 2024
- 440 Pages
Global
From €4551EUR$5,000USD£3,901GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Clinical Trials
- April 2024
- 200 Pages
Global
€4551EUR$5,000USD£3,901GBP
- Report
- April 2023
- 200 Pages
United States
From €3413EUR$3,750USD£2,926GBP
- Report
- May 2023
- 147 Pages
Global
From €4504EUR$4,949USD£3,861GBP
- Drug Pipelines
- April 2024
- 210 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- November 2022
- 117 Pages
Global
From €4095EUR$4,500USD£3,511GBP

Carboplatin is a chemotherapy drug used to treat lung cancer. It is a platinum-based drug, which works by interfering with the growth of cancer cells. It is often used in combination with other drugs, such as paclitaxel, to treat non-small cell lung cancer. Carboplatin is also used to treat other types of cancer, such as ovarian and bladder cancer.
Carboplatin is generally well-tolerated, with fewer side effects than other chemotherapy drugs. Common side effects include nausea, vomiting, and hair loss. It is important to note that Carboplatin can cause serious side effects, such as kidney damage and hearing loss.
The Carboplatin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Pfizer, Bristol-Myers Squibb, Merck, and AstraZeneca. Other companies, such as Teva Pharmaceuticals and Mylan, also offer generic versions of Carboplatin. Show Less Read more